{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:44:34Z","timestamp":1790185474135,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0013270","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000}}],"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec019\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Brucellosis is the most common zoonotic disease worldwide, with significant heterogeneity in the literature regarding the risk factors and rate of relapse, we reviewed cases of confirmed brucellosis in Saudi Arabia, looking at the rate of relapse, characteristics of relapse cases, and compared it to the existing literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec020\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on confirmed cases of brucellosis. Cases with suspected relapse, as noted in medical charts, were identified. A detailed review of clinical and laboratory findings, along with associated outcomes, was performed to confirm instances of brucellosis relapse. Descriptive analysis was then undertaken to characterize confirmed relapse cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec021\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 1,049 confirmed brucellosis cases over eight years, 73 cases were initially suspected of potential relapse. After excluding misdiagnosis and repeat exposures cases, there were 37 cases confirmed as relapses, resulting in a relapse rate of 3.53%. When considering only cases where patients adhered to the full treatment regimen, 10 patients were considered as \u201ctrue relapse\u201d cases, reducing the relapse rate to 0.95%. Among the 10 true relapse cases, four initially presented with bacteremia, and all ten patients had elevated\n                      <jats:italic>Brucella<\/jats:italic>\n                      titers. None had focal infection initially. All true relapse patients received Doxycycline as the core agent, with rifampin or streptomycin as a second agent. Upon relapse, four patients developed spondylitis, and three had bacteremia. Eight patients received an extended duration and\/or triple therapy, and only one patient relapsed for a third time with an infected cardiac device. No mortalities were recorded within 90 days of completing relapse treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec022\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The relapse rate observed in this study is lower than previously reported in the literature. Further research on brucellosis relapse should prioritize investigating treatment adherence and establishing a standardized definition, which might help address the current discrepancies in reported data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0013270","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T14:00:26Z","timestamp":1751896826000},"page":"e0013270","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Brucellosis relapse: Rate, patient characteristics, and clinical outcomes in an endemic region"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4652-8797","authenticated-orcid":true,"given":"Ibrahim","family":"Bahabri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anadel","family":"Hakeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Alturki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutaz","family":"Althobaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameera","family":"Aljohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Bosaeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"pntd.0013270.ref001","volume-title":"Madkour\u2019s Brucellosis","author":"DMM Madkour","year":"2000"},{"key":"pntd.0013270.ref002","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-225865","article-title":"Brucellosis in renal transplant recipients: a comparative review of 5 cases","volume":"2018","author":"F Inayat","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"2","key":"pntd.0013270.ref003","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/jhin.2001.1004","article-title":"Brucellosis due to blood transfusion","volume":"49","author":"M Doganay","year":"2001","journal-title":"J Hosp Infect"},{"issue":"9017","key":"pntd.0013270.ref004","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(96)90839-9","article-title":"Brucella melitensis--a sexually transmissible agent?","volume":"347","author":"BG Mantur","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"pntd.0013270.ref005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3325\/cmj.2010.51.289","article-title":"Brucellosis - regionally emerging zoonotic disease?","volume":"51","author":"M Gwida","year":"2010","journal-title":"Croat Med J"},{"issue":"9","key":"pntd.0013270.ref006","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3201\/eid2909.230052","article-title":"Global estimate of human brucellosis incidence","volume":"29","author":"CG Laine","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"pntd.0013270.ref007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jegh.2015.09.001","article-title":"Trends of reported human cases of brucellosis, Kingdom of Saudi Arabia, 2004-2012","volume":"6","author":"AD Aloufi","year":"2016","journal-title":"J Epidemiol Glob Health"},{"issue":"1","key":"pntd.0013270.ref008","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijid.2005.10.011","article-title":"Acute brucellosis: presentation, diagnosis, and treatment of 144 cases","volume":"11","author":"P Andriopoulos","year":"2007","journal-title":"Int J Infect Dis"},{"issue":"4","key":"pntd.0013270.ref009","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199607000-00003","article-title":"Complications associated with Brucella melitensis infection: a study of 530 cases","volume":"75","author":"JD Colmenero","year":"1996","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"pntd.0013270.ref010","first-page":"233","article-title":"Brucellosis in humans--etiology, diagnostics, clinical forms","volume":"20","author":"EM Gali\u0144ska","year":"2013","journal-title":"Ann Agric Environ Med"},{"issue":"5","key":"pntd.0013270.ref011","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/clinids\/20.5.1241","article-title":"Characteristics of and risk factors for relapse of brucellosis in humans","volume":"20","author":"J Ariza","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pntd.0013270.ref012","first-page":"173","article-title":"TNF-alpha, TGF-beta, IL-10, IL-6 and IFN-gamma gene polymorphisms as risk factors for brucellosis","volume":"32","author":"I Karaoglan","year":"2009","journal-title":"New Microbiol"},{"issue":"5","key":"pntd.0013270.ref013","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1744-313X.2006.00626.x","article-title":"Th-1 cytokines gene polymorphism in human brucellosis","volume":"33","author":"S Davoudi","year":"2006","journal-title":"Int J Immunogenet"},{"issue":"1","key":"pntd.0013270.ref014","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0163-4453(98)93342-4","article-title":"Multivariate model for predicting relapse in human brucellosis","volume":"36","author":"J Solera","year":"1998","journal-title":"J Infect"},{"issue":"9","key":"pntd.0013270.ref015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002424","article-title":"Ex vivo innate immune cytokine signature of enhanced risk of relapsing brucellosis","volume":"7","author":"KE Feldman","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0013270.ref016","first-page":"46","article-title":"Relapsed human brucellosis and related risk factors","volume":"25","author":"SM Alavi","year":"2009","journal-title":"Pak J Med Sci"},{"key":"pntd.0013270.ref017","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijid.2017.06.002","article-title":"Epidemiological characteristics of human brucellosis in Hamadan Province during 2009-2015: results from the National Notifiable Diseases Surveillance System","volume":"61","author":"S Nematollahi","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"3","key":"pntd.0013270.ref018","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4314\/gmj.v55i3.5","article-title":"Epidemiological features of brucellosis and factors affecting its treatment failure and relapse in Qom Province, Iran","volume":"55","author":"A Mohammadbeigi","year":"2021","journal-title":"Ghana Med J"},{"issue":"6","key":"pntd.0013270.ref019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2009.06.031","article-title":"Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature","volume":"14","author":"T Buzgan","year":"2010","journal-title":"Int J Infect Dis"},{"key":"pntd.0013270.ref020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2334-3-5","article-title":"Diagnosis of recent and relapsed cases of human brucellosis by PCR assay","volume":"3","author":"LF Nimri","year":"2003","journal-title":"BMC Infect Dis"},{"issue":"10","key":"pntd.0013270.ref021","first-page":"1562","article-title":"Human brucellosis in Northern Saudi Arabia","volume":"26","author":"SM Fallatah","year":"2005","journal-title":"Saudi Med J"},{"issue":"3","key":"pntd.0013270.ref022","doi-asserted-by":"crossref","first-page":"149","DOI":"10.21608\/aeji.2018.13526","article-title":"Brucellosis relapse: a retrospective study of risk factors among Saudi patients","volume":"8","author":"E Abd elbaser","year":"2018","journal-title":"Afro-Egyptian J Infectious and Endemic Dis"},{"issue":"11","key":"pntd.0013270.ref023","article-title":"Brucellosis in Saudi children: presentation, complications, and treatment outcome","volume":"12","author":"SS Qasim","year":"2020","journal-title":"Cureus"},{"issue":"11","key":"pntd.0013270.ref024","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1128\/JCM.38.11.4000-4005.2000","article-title":"Evaluation of an immunocapture-agglutination test (Brucellacapt) for serodiagnosis of human brucellosis","volume":"38","author":"A Ordu\u00f1a","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"1","key":"pntd.0013270.ref025","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00073-19","article-title":"Laboratory diagnosis of human brucellosis","volume":"33","author":"P Yagupsky","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"pntd.0013270.ref026","author":"WHO","year":"2006"},{"issue":"12","key":"pntd.0013270.ref027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040317","article-title":"Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations","volume":"4","author":"J Ariza","year":"2007","journal-title":"PLoS Med"},{"issue":"2","key":"pntd.0013270.ref028","first-page":"636","article-title":"Treatment of brucellosis: a systematic review of studies in recent twenty years","volume":"4","author":"SM Alavi","year":"2013","journal-title":"Caspian J Intern Med"},{"issue":"1","key":"pntd.0013270.ref029","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12879-020-4763-z","article-title":"Sero-prevalence and risk factors of brucellosis among suspected febrile patients attending a referral hospital in southern Saudi Arabia (2014-2018)","volume":"20","author":"AM Alkahtani","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"2","key":"pntd.0013270.ref030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0318503","article-title":"Spatio-temporal analysis of human brucellosis distribution in Neyshabur, Iran from 2015 to 2022, a cross-sectional study","volume":"20","author":"A Fathabadi","year":"2025","journal-title":"PLoS One"},{"key":"pntd.0013270.ref031","doi-asserted-by":"crossref","first-page":"1259479","DOI":"10.3389\/fmicb.2023.1259479","article-title":"Epidemiology, clinical manifestations, and laboratory findings of 1,590 human brucellosis cases in Ningxia, China","volume":"14","author":"B Liu","year":"2023","journal-title":"Front Microbiol"},{"key":"pntd.0013270.ref032","doi-asserted-by":"crossref","first-page":"1541277","DOI":"10.3389\/fmicb.2025.1541277","article-title":"Epidemiological, clinical, and laboratory characteristics of 581 human brucellosis cases in Xinjiang, China","volume":"16","author":"B Luo","year":"2025","journal-title":"Front Microbiol"},{"issue":"5","key":"pntd.0013270.ref033","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/clinids\/20.5.1241","article-title":"Characteristics of and risk factors for relapse of brucellosis in humans","volume":"20","author":"J Ariza","year":"1995","journal-title":"Clin Infectious Dis"},{"issue":"5","key":"pntd.0013270.ref034","doi-asserted-by":"crossref","DOI":"10.1111\/tbed.14502","article-title":"The perspective of antibiotic therapeutic challenges of brucellosis in the Middle East and North African countries: Current situation and therapeutic management","volume":"69","author":"G Wareth","year":"2022","journal-title":"Transbound Emerg Dis"},{"issue":"2","key":"pntd.0013270.ref035","article-title":"Establishment of brucellosis relapse and complications registry: a study protocol","volume":"62","author":"F Keramat","year":"2021","journal-title":"J Prev Med Hyg"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0013270","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T18:03:54Z","timestamp":1752170634000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013270"}},"subtitle":[],"editor":[{"given":"Joseph M.","family":"Vinetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013270","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]}}}